Eagle Pharmaceuticals, Inc.
USD0.67
+0.07 (+11.67%)
CEO
Michael Graves
IPO Date
2014-02-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.58
Prev. Close
$0.60
Day Low
$0.58
Day High
$0.67
52W Low
$0.09
52W High
$3.87
Market Cap
$0.01B
Volume
0.00M
| 3,800 |
| $0.00 |
| 29 Feb 2024 | Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | F-InKind | Disposed | 1,589 | $6.44 |
| 29 Feb 2024 | Tarriff Scott | 10 percent owner | A-Award | Acquired | 12,950 | $0.00 |
| 29 Feb 2024 | Tarriff Scott | 10 percent owner | F-InKind | Disposed | 3,154 | $6.44 |
| 6 Feb 2024 | Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | F-InKind | Disposed | 934 | $5.85 |
| 9 Jan 2024 | Cahill Brian Joseph | Chief Financial Officer | F-InKind | Disposed | 735 | $5.13 |
| 9 Jan 2024 | Tarriff Scott | 10 percent owner | F-InKind | Disposed | 4,322 | $5.13 |
| 22 Dec 2023 | Graves Michael | director, officer: Interim Executive Chair & PEO | A-Award | Acquired | 293,000 | $5.01 |
| 20 Dec 2023 | Cahill Brian Joseph | Chief Financial Officer | F-InKind | Disposed | 452 | $4.76 |